The United States Food and Drug Administration (“FDA”) issued a statement (the “Statement”) clarifying its position on cannabidiol (“CBD”) products in the wake of the Agriculture Improvement Act of 2018 (the “2018 Farm Bill”) signed December 20, 2018.¹ The 2018 Farm Bill is a broad piece of legislation that regulates agricultural programs ranging from income support... READ MORE
FDA Clarifies Position on CBD After Passage of 2018 Farm Bill
Posted on January 18, 2019 in HR Insights for Health Care
Published by: Hall Render
